Recruitment Strategies Pay Off In Epilepsy Trials
Source: PRA Health Sciences
A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed partial epileps.
A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.
        access the Case Study!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
             
        
        
            Case Studies & White Papers
             
        
        
            Extensive Product Database
             
        
        
            Members-Only Premium Content
             
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
        Subscribe to Clinical Leader
        X
    
    
        Subscribe to Clinical Leader
    
    